Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3176-3186
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3176
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3176
Table 3 Clinical features and univariate prognosis of 49 patients with follicular lymphoma
Factors | 3-year OS, % (SE) | 5-year OS, % (SE) | Log-rank (P value) | |
Sex | ||||
M (30) | 86.7 (0.05) | 63.3 (0.09) | 0.185 | |
F (19) | 78.9 (0.09) | 63.1 (0.13) | ||
Age (yr) | ||||
≤ 60 (32) | 84.3 (0.05) | 71.9 (0.08) | 0.584 | |
> 60 (17) | 82.4 (0.08) | 70.6 (0.13) | ||
The presence or absence of B symptoms | ||||
Y (31) | 77.4 (0.08) | 58.1 (0.13) | 0.237 | |
N (18) | 88.9 (0.06) | 72.2 (0.09) | ||
Stage | ||||
I-II (17) | 94.1 (0.05) | 94.1 (0.05) | 0.043 | |
III-IV (32) | 78.1 (0.06) | 65.6 (0.10) | ||
Pathological grading | ||||
I (3) | 100.0 | 100.0 | 0.321 | |
II (16) | 87.5 (0.07) | 68.7 (0.12) | ||
III (30) | 80.0 (0.05) | 73.3 (0.11) | ||
BM infiltration | ||||
Y (10) | 70.0 (0.13) | 30.0 (0.15) | 0.007 | |
N (39) | 89.7 (0.04) | 79.5 (0.08) | ||
Involved lymph node area | ||||
≤ 4 (36) | 86.1 (0.05) | 72.2 (0.08) | 0.054 | |
> 4 (13) | 76.9 (0.12) | 53.8 (0.19) | ||
Hepatomegaly | ||||
Y (2) | 100.0 | 100.0 | 0.835 | |
N (47) | 85.1 (0.05) | 74.4 (0.08) | ||
Splenomegaly | ||||
Y (10) | 80.0 (0.10) | 60.0 (0.14) | 0.169 | |
N (39) | 84.6 (0.05) | 76.9 (0.09) | ||
LDH | ||||
Normal (14) | 85.7 (0.10) | 71.4 (0.10) | 0.312 | |
High (35) | 82.9 (0.05) | 68.6 (0.09) | ||
Hb | ||||
< 120 g/L (20) | 75.0 (0.09) | 45.0 (0.12) | 0.011 | |
≥ 120 g/L (29) | 89.7 (0.04) | 75.9 (0.09) | ||
WBC | ||||
≤ 4 × 109/L (11) | 100 | 72.7 (0.18) | 0.481 | |
> 4 × 109/L (38) | 84.2 (0.05) | 65.8 (0.08) | ||
WBC | ||||
≤ 10 × 109/L (42) | 88.1 (0.05) | 66.7 (0.08) | 0.813 | |
> 10 × 109/L (7) | 71.4 (0.21) | 57.1 (0.21) | ||
LYM | ||||
≤ 1 × 109/L (25) | 80.0 (0.09) | 68.0 (0.15) | 0.494 | |
> 1 × 109/L (24) | 87.5 (0.05) | 66.7 (0.09) | ||
PLT | ||||
≤ 80 × 109/L (9) | 100 | 66.7 (0.19) | 0.998 | |
> 80 × 109/L (40) | 82.5 (0.06) | 70.0 (0.08) | ||
ALB | ||||
≤ 35 g/L (6) | 83.3 (0.15) | 66.7 (0.19) | 0.941 | |
> 35 g/L (43) | 87.4 (0.05) | 67.2 (0.08) | ||
GLB | ||||
≤ 34 g/L (44) | 87.9 (0.05) | 66.5 (0.08) | 0.758 | |
> 34 g/L (5) | 80.0 (0.18) | 80.0 (0.18) | ||
Ki-67 | ||||
≤ 50% (27) | 96.2 (0.04) | 91.3 (0.06) | 0.004 | |
> 50% (22) | 83.3 (0.15) | 31.2 (0.25) | ||
Bcl-6+ | 32 | 83.9 (0.07) | 74.6 (0.09) | 0.926 |
Bcl-6- | 17 | 100 | 68.6 (0.19) | |
CD10+ | 35 | 85.7 (0.07) | 64.6 (0.11) | 0.293 |
CD10- | 14 | 90.9 (0.09) | 90.9 (0.09) | |
Bcl-2+ | 25 | 91.4 (0.06) | 76.4 (0.09) | 0.493 |
Bcl-2- | 24 | 80 (0.10) | 66.7 (0.15) |
- Citation: Wu H, Sun HC, Ouyang GF. Clinical features and prognostic factors in 49 patients with follicular lymphoma at a single center: A retrospective analysis. World J Clin Cases 2023; 11(14): 3176-3186
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3176.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3176